Using a proprietary metabolite profiling platform and customized machine learning algorithms, Olaris can identify individual molecular profiles so detailed that the guess work in how to treat a patient's disease is removed. By collaborating with patients, clinicians, hospitals, payers and biopharma Olaris generates data with high clinical utility. This data enables healthcare providers and their patients to pursue the most effective treatments.
Additionally, the comprehensive Olaris profiles can help pharmaceutical companies take novel approaches to develop targeted medicines, adding value and efficiency to our health-care system.
OLARIS BoR COMBINES METABOLITES & MACHINE LEARNING
FACTORS BEYOND GENETICS INFLUENCE DRUG RESPONSE
The Olaris platform produces personalized “Biomarkers of Response (BoR)” to readily differentiate R from NR